Canola Oil Recommendations for Patients with Atherosclerosis

Indications and Recommended Dosage

Adults with established atherosclerotic disease may replace saturated‑fat‑rich oils with canola oil at a daily intake of 25–40 g (≈2–3 tablespoons), adjusted to individual energy requirements. This recommendation is supported by the 2022 Cardiovascular Research guideline. 1

The 2022 Cardiovascular Research guideline lists canola oil together with olive, soybean, sunflower, safflower, and corn oils as the preferred vegetable oils for atherosclerosis prevention; these should substitute butter, animal fats, and tropical saturated oils in the habitual diet. 1

Mechanism	Effect	Evidence Strength
Replacement of saturated fats with PUFA‑rich vegetable oils	29 % reduction in coronary heart disease incidence (adequately controlled trials)	High‑quality evidence
Substituting 5 % of total energy from omega‑6 PUFAs for saturated fats	25 % reduction in cardiovascular disease incidence	Moderate evidence
Canola oil’s ≈10 % omega‑3 PUFA (α‑linolenic acid) content	Provides anti‑inflammatory benefit superior to most other vegetable oils	Moderate evidence
General unsaturated‑fat replacement	Lowers LDL‑cholesterol, reduces blood pressure, improves insulin sensitivity, diminishes subclinical inflammation, and modulates hemostasis	Consistent evidence across multiple trials

Use canola oil as the primary cooking oil to replace butter, lard, coconut oil, or palm oil, aligning with the 2022 Cardiovascular Research guideline. 1
For optimal cardiovascular benefit, incorporate canola oil within a Mediterranean‑style dietary pattern that emphasizes fruits, vegetables, whole grains, legumes, and fish (guideline‑based recommendation).

Compared with corn, safflower, and sunflower oils (which contain <1 % omega‑3 PUFA), canola oil’s 10 % omega‑3 PUFA content offers an advantage; mixed omega‑3/omega‑6 PUFA interventions have shown significant CHD event reductions, whereas omega‑6‑only interventions trend toward ~16 % more events (not statistically significant). This is reported in Advances in Nutrition. 6
While extra‑virgin olive oil receives special emphasis for primary prevention (PREDIMED study showing 35 % lower CVD risk in the highest consumption tertile), canola oil remains an evidence‑based alternative according to the 2022 Cardiovascular Research guideline. 1

Canola oil is safe for patients with established atherosclerosis and has no specific contraindications beyond those applicable to all vegetable oils; the safety profile is affirmed by the 2022 Cardiovascular Research guideline. 1
Consistent evidence demonstrates cardiovascular benefit when canola oil replaces saturated‑fat sources, reinforcing its safety and efficacy. 1

High‑temperature cooking can cause lipid peroxidation of PUFA in vegetable oils, generating oxidative products that may promote cardiovascular disease; therefore, use canola oil for low‑to‑medium heat cooking or select high‑oleic canola formulations for higher‑heat applications. (Evidence from Advances in Nutrition.) 6